{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:08:37Z","timestamp":1768266517766,"version":"3.49.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T00:00:00Z","timestamp":1622764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"AstraZeneca Portugal"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>We aimed to identify the perception of physicians on the limitations and delays for diagnosing, staging and treatment of lung cancer in Portugal.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Portuguese physicians were invited to participate an electronic survey (Feb-Apr-2020). Descriptive statistical analyses were performed, with categorical variables reported as absolute and relative frequencies, and continuous variables with non-normal distribution as median and interquartile range (IQR). The association between categorical variables was assessed through Pearson\u2019s chi-square test. Mann-Whitney test was used to compare categorical and continuous variables (Stata v.15.0).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>Sixty-one physicians participated in the study (45 pulmonologists, 16 oncologists), with n = 26 exclusively assisting lung cancer patients. Most experts work in public hospitals (90.16%) in Lisbon (36.07%). During the last semester of 2019, responders performed a median of 85 (IQR 55\u2013140) diagnoses of lung cancer. Factors preventing faster referral to the specialty included poor articulation between services (60.0%) and patients low economic\/cultural level (44.26%). Obtaining National Drugs Authority authorization was one of the main reasons (75.41%) for delaying the begin of treatment. The cumulative lag-time from patients\u2019 admission until treatment ranged from 42\u201361 days. Experts believe that the time to diagnosis could be optimized in around 11.05 days [IQR 9.61\u201312.50]. Most physicians (88.52%) started treatment before biomarkers results motivated by performance status deterioration (65.57%) or high tumor burden (52.46%). Clinicians exclusively assisting lung cancer cases reported fewer delays for obtaining authorization for biomarkers analysis (p = 0.023). Higher waiting times for surgery (p = 0.001), radiotherapy (p = 0.004), immunotherapy (p = 0.003) were reported by professionals from public hospitals.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Physicians believe that is possible to reduce delays in all stages of lung cancer diagnosis with further efforts from multidisciplinary teams and hospital administration.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0252529","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T17:26:49Z","timestamp":1622827609000},"page":"e0252529","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis"],"prefix":"10.1371","volume":"16","author":[{"given":"Fernando","family":"Barata","sequence":"first","affiliation":[]},{"given":"Paula","family":"Fidalgo","sequence":"additional","affiliation":[]},{"given":"Sara","family":"Figueiredo","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-8608","authenticated-orcid":true,"given":"Fernanda S.","family":"Tonin","sequence":"additional","affiliation":[]},{"given":"Filipa","family":"Duarte-Ramos","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2021,6,4]]},"reference":[{"issue":"1","key":"pone.0252529.ref001","article-title":"Global Epidemiology of Lung Cancer","volume":"85","author":"JA Barta","year":"2019","journal-title":"Ann Glob Health"},{"key":"pone.0252529.ref002","article-title":"Progress in cancer mortality, incidence, and survival: a global overview","author":"C Santucci","year":"2020","journal-title":"Eur J Cancer Prev"},{"key":"pone.0252529.ref003","unstructured":"The Global Cancer Observatory. Portugal\u2014Globocan 2018 2019 [cited 2021 01 Feb 2021]. Available from: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/620-portugal-fact-sheets.pdf."},{"issue":"7","key":"pone.0252529.ref004","doi-asserted-by":"crossref","first-page":"A626","DOI":"10.1016\/j.jval.2014.08.2228","article-title":"Cost and Burden of Non-Small Cell Lung Cancer\u2019s in Portugal","volume":"17","author":"M Borges","year":"2014","journal-title":"Value Health"},{"issue":"149","key":"pone.0252529.ref005","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0045-2018","article-title":"How long is too long? A scoping review of health system delays in lung cancer","volume":"27","author":"A Malalasekera","year":"2018","journal-title":"Eur Respir Rev"},{"issue":"6","key":"pone.0252529.ref006","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.2196\/jmir.6336","article-title":"The Role of Web-Based Health Information in Help-Seeking Behavior Prior to a Diagnosis of Lung Cancer: A Mixed-Methods Study","volume":"19","author":"J Mueller","year":"2017","journal-title":"J Med Internet Res"},{"issue":"2","key":"pone.0252529.ref007","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/1759-7714.12950","article-title":"Predicting delays in lung cancer diagnosis and staging","volume":"10","author":"V Leiro-Fernandez","year":"2019","journal-title":"Thorac Cancer"},{"issue":"3","key":"pone.0252529.ref008","first-page":"221","article-title":"Early diagnosis of lung cancer: the great challenge. Epidemiological variables, clinical variables, staging and treatment","volume":"32","author":"JA Barros","year":"2006","journal-title":"J Bras Pneumol"},{"issue":"5","key":"pone.0252529.ref009","doi-asserted-by":"crossref","first-page":"330","DOI":"10.7326\/M13-2771","article-title":"Force USPST. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"VA Moyer","year":"2014","journal-title":"Ann Intern Med"},{"issue":"1","key":"pone.0252529.ref010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1164\/rccm.201410-1777CI","article-title":"Lung cancer screening","volume":"191","author":"LT Tanoue","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"pone.0252529.ref011","doi-asserted-by":"crossref","first-page":"e754","DOI":"10.1016\/S1470-2045(17)30861-6","article-title":"European position statement on lung cancer screening","volume":"18","author":"M Oudkerk","year":"2017","journal-title":"Lancet Oncol"},{"issue":"5","key":"pone.0252529.ref012","doi-asserted-by":"crossref","first-page":"e000577","DOI":"10.1136\/esmoopen-2019-000577","article-title":"Implementation of lung cancer screening in Europe: challenges and potential solutions: summary of a multidisciplinary roundtable discussion","volume":"4","author":"JK Field","year":"2019","journal-title":"ESMO Open"},{"issue":"12","key":"pone.0252529.ref013","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacr.2013.09.013","article-title":"Controversies in lung cancer screening","volume":"10","author":"RR Gill","year":"2013","journal-title":"J Am Coll Radiol"},{"issue":"10","key":"pone.0252529.ref014","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1164\/rccm.201502-0345LE","article-title":"Lung Cancer Screening: The Balance between Harm and Benefit","volume":"191","author":"JJ Zulueta","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 1","key":"pone.0252529.ref015","first-page":"S1","article-title":"BTS recommendations to respiratory physicians for organising the care of patients with lung cancer","volume":"53","year":"1998","journal-title":"The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee. Thorax"},{"issue":"10","key":"pone.0252529.ref016","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1200\/JOP.18.00125","article-title":"Times to Diagnosis and Treatment of Lung Cancer in New South Wales, Australia: A Multicenter, Medicare Data Linkage Study","volume":"14","author":"A Malalasekera","year":"2018","journal-title":"J Oncol Pract"},{"key":"pone.0252529.ref017","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lungcan.2017.08.011","article-title":"Timeliness of access to lung cancer diagnosis and treatment: A scoping literature review","volume":"112","author":"MM Jacobsen","year":"2017","journal-title":"Lung Cancer"},{"issue":"1","key":"pone.0252529.ref018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12885-018-5169-9","article-title":"Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review","volume":"19","author":"S Cassim","year":"2019","journal-title":"BMC Cancer"},{"issue":"2","key":"pone.0252529.ref019","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00520-016-3428-3","article-title":"Barriers to lung cancer care: health professionals\u2019 perspectives","volume":"25","author":"J Dunn","year":"2017","journal-title":"Support Care Cancer"},{"issue":"2","key":"pone.0252529.ref020","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00520-020-05532-8","article-title":"Barriers to lung cancer referral, diagnosis, and treatment in Central America and the Caribbean: the health professionals\u2019 perspectives","volume":"29","author":"A Maklouf-Quiros","year":"2021","journal-title":"Support Care Cancer"},{"issue":"6","key":"pone.0252529.ref021","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3747\/co.24.3655","article-title":"Wait times for diagnosis and treatment of lung cancer: a single-centre experience","volume":"24","author":"C Labbe","year":"2017","journal-title":"Curr Oncol"},{"issue":"3","key":"pone.0252529.ref022","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/crj.12217","article-title":"Delays for diagnosis and treatment of lung cancers: a systematic review","volume":"10","author":"F Vinas","year":"2016","journal-title":"Clin Respir J"},{"issue":"11","key":"pone.0252529.ref023","doi-asserted-by":"crossref","first-page":"e025895","DOI":"10.1136\/bmjopen-2018-025895","article-title":"Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP)","volume":"9","author":"U Menon","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"pone.0252529.ref024","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1200\/JOP.2015.009605","article-title":"Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based Study","volume":"12","author":"RM Vidaver","year":"2016","journal-title":"J Oncol Pract"},{"issue":"1","key":"pone.0252529.ref025","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.lungcan.2006.07.001","article-title":"Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline","volume":"54","author":"RP Hermens","year":"2006","journal-title":"Lung Cancer"},{"key":"pone.0252529.ref026","unstructured":"Statistics Portugal. Instituto Nacional de Estat\u00edstica\u2014Os hospitais do sector p\u00fablico asseguraram mais de 70% dos internamentos e cirurgias\u20142007\u20132017. 2019 [cited 2021 01 Feb 2021]. Available from: www.ine.pt"},{"issue":"2","key":"pone.0252529.ref027","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/thoraxjnl-2014-205517","article-title":"The role of receipt and timeliness of treatment in socioeconomic inequalities in lung cancer survival: population-based, data-linkage study","volume":"70","author":"LF Forrest","year":"2015","journal-title":"Thorax"},{"issue":"5","key":"pone.0252529.ref028","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1136\/thoraxjnl-2016-209591","article-title":"Socioeconomic position and delays in lung cancer diagnosis: should we target the more deprived?","volume":"72","author":"DR Baldwin","year":"2017","journal-title":"Thorax"},{"issue":"2","key":"pone.0252529.ref029","doi-asserted-by":"crossref","first-page":"020901","DOI":"10.7189\/jogh.06.020901","article-title":"Preventing delayed diagnosis of cancer: clinicians\u2019 views on main problems and solutions","volume":"6","author":"LT Car","year":"2016","journal-title":"J Glob Health"},{"issue":"2","key":"pone.0252529.ref030","first-page":"e77","article-title":"Why do delays to diagnosis and treatment of lung cancer occur? A mixed methods study of insights from Australian clinicians","volume":"17","author":"A Malalasekera","year":"2020","journal-title":"Asia Pac J Clin Oncol"},{"key":"pone.0252529.ref031","unstructured":"Barata F. Cancro de Pulm\u00e3o: N\u00fameros, Rastreio e Inova\u00e7\u00e3o. 13\u00b0 Relat\u00f3rio do Observat\u00f3rio Nacional das Doen\u00e7as Respirat\u00f3rias 2016\/2017\u2014Panorama das Doen\u00e7as Respirat\u00f3rias em Portugal, Retrato da Sa\u00fade 2018 Observat\u00f3rio Nacional das Doen\u00e7as Respirat\u00f3rias. 2018."},{"issue":"1","key":"pone.0252529.ref032","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s10916-017-0873-6","article-title":"Reducing Bottlenecks to Improve the Efficiency of the Lung Cancer Care Delivery Process: A Process Engineering Modeling Approach to Patient-Centered Care","volume":"42","author":"F Ju","year":"2017","journal-title":"J Med Syst"},{"issue":"4","key":"pone.0252529.ref033","first-page":"456","article-title":"\u2019One-stop shop\u2019: lung cancer patients\u2019 and caregivers\u2019 perceptions of multidisciplinary care in a community healthcare settin","volume":"4","author":"SK Kedia","year":"2015","journal-title":"Transl Lung Cancer Res"},{"issue":"3","key":"pone.0252529.ref034","first-page":"248","article-title":"How to maintain multidisciplinary treatment schedules","volume":"3","author":"R Gopal","year":"2005","journal-title":"J Support Oncol"},{"issue":"2","key":"pone.0252529.ref035","first-page":"64","article-title":"Addressing low literacy and health literacy in clinical oncology practice","volume":"8","author":"SF Garcia","year":"2010","journal-title":"J Support Oncol"},{"key":"pone.0252529.ref036","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.pmedr.2018.05.013","article-title":"A national survey of primary care physicians: Perceptions and practices of low-dose CT lung cancer screening","volume":"11","author":"JM Eberth","year":"2018","journal-title":"Prev Med Rep"},{"issue":"suppl 27","key":"pone.0252529.ref037","article-title":"Collaboration with commercial payor to eliminate prior authorization","volume":"37","author":"M Sharma","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"pone.0252529.ref038","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1093\/annonc\/mdu145","article-title":"Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer","volume":"25","author":"KM Kerr","year":"2014","journal-title":"Ann Oncol"},{"issue":"suppl_4","key":"pone.0252529.ref039","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"PE Postmus","year":"2017","journal-title":"Ann Oncol"},{"issue":"15","key":"pone.0252529.ref040","article-title":"Characterizing delays in tumor biomarker testing","volume":"33","author":"M Veljovic","year":"2015","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"pone.0252529.ref041","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1097\/JTO.0b013e318217b623","article-title":"Treatment delays in non-small cell lung cancer and their prognostic implications","volume":"6","author":"R Diaconescu","year":"2011","journal-title":"J Thorac Oncol"},{"issue":"344","key":"pone.0252529.ref042","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1080\/01621459.1973.10481428","article-title":"Effects of Time and Memory Factors on Response in Surveys","volume":"68","author":"S Sudman","year":"1973","journal-title":"Journal of the American Statistical Association"},{"issue":"4","key":"pone.0252529.ref043","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/COC.0000000000000665","article-title":"Response Rate and Nonresponse Bias in Oncology Survey Studies","volume":"43","author":"AD Parekh","year":"2020","journal-title":"Am J Clin Oncol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T17:27:49Z","timestamp":1622827669000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0252529"}},"subtitle":[],"editor":[{"given":"Wen-Chi","family":"Chou","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2021,6,4]]},"references-count":43,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0252529","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,4]]}}}